The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

FDA approves RHHBY's Susvimo for diabetic retinopathy, its third indication, offering 9-month relief with one treatment.

Basel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Diabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular ...

Corticosteroids are potent drugs used to reduce inflammation in the body's tissues. They are different from anabolic steroids. These are illegally used by some athletes to increase muscle tone.

Although some biologic medications have been reformulated to reduce the sting of the injection, for many people the pain and anxiety associated with injections may prevent them from managing their ...

Louisiana has resumed executions using a novel nitrogen gas method — a legacy, in part, of problems getting the drugs used for lethal injections. But the injection method remains on the books in ...

The investigation uncovered 245 joint injections between May 2023 and October 2024 administered at Penn National in violation of the authority’s regulation on joint injection stand-down times.